Advancing our understanding of the brain through the development and application of molecular imaging agents
Spotlight: Intern Orvin Pierre with the Harvard Gazette
An intern with the ChemNeuro group, Orvin Pierre, recently shared his journey towards medicine in the Harvard Gazette. In the interview with the Harvard junior, he reflects upon his innate desire to problem-solve, piecing together studies in science and humanism in preparation to be a physician.
Eikonizo Therapeutics Enter Agreement to Develop Treatments for Patients with Rare Diseases
Congratulations to Jacob Hooker, the academic founder of Eikonizo Therapeutics, for entering a collaboration agreement with the McQuade Center for Strategic Research and Development, to develop inhibitors of histone deacetylase-6 (HDAC6) focused on treating amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, and other diseases. The group is excited to have the resources needed to get […]
Jacob Hooker Named Interim Editor-in-Chief for the ACS Chemical Neuroscience
Congratulations to Jacob Hooker for being named Interim Editor-in-Chief of the ACS Chemical Neuroscience! The ACS Chemical Neuroscience highlights biophysical, bioengineering, chemical, and quantitative biological approaches of aspects of chemical neurobiology or bio-neurochemistry.